NIH-funded research NIH-funded research

A centralized hub for advanced immunological analysis

Official title: Molecular Immunology Core

Funded at Massachusetts General Hospital · NIH-11035225 · Data updated 2026-11-12

This study is working on a new center that will help scientists better understand how the immune system reacts to lung transplants, which could lead to better outcomes for patients like you.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startMarch 23, 2023
Project endFebruary 29, 2028
Funding year2025
Award (this year)$659,958
NIH project number5U19AI174967-03
Project IDNIH-11035225 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients undergoing lung transplantation or those with conditions requiring advanced immunological analysis.

Less likely to help

Patients who are not undergoing transplantation or do not have immune-related conditions may not benefit from this research.

What this research studies

This research focuses on creating a centralized facility that will enhance the analysis of biological samples related to immune responses, particularly in the context of lung transplant tolerance. It will streamline various assays and procedures to ensure consistency and best practices across multiple projects. The facility will consist of several specialized cores that will work together to improve the efficiency and rigor of experiments aimed at understanding how to achieve tolerance in lung transplants. Patients may benefit from improved transplant outcomes through better understanding and management of immune responses.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for achieving tolerance in lung transplants, potentially reducing the need for lifelong immunosuppression.

How similar studies have gone: Previous research in immunological analysis and transplant tolerance has shown promising results, indicating that this approach could build on established findings.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Kean, Leslie S — Massachusetts General Hospital
  • Study coordinator: Kean, Leslie S

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.